REGN· Regeneron Pharmaceuticals
Insider buys/sells · last 6 mo · open market only
| Transactions | Total $ | |
|---|---|---|
| Buys | 0 | $0 |
| Sells | 12 | $71K |
Held alongside REGN
Top stocks REGN's whales also own — ranked by holder overlap
Quarterly ownership history
Last 6 quarters
REGN Financials
Live via yfinance — refreshed daily.
Valuation
Market capitalization$74.9B
Enterprise value$66.7B
EV / EBITDA (TTM)15.21
P/E ratio (TTM)17.45
Forward P/E13.29
P/S ratio5.02
P/B ratio2.35
PEG ratio1.46
Cash Flow
Operating cash flow (TTM)$5.0B
Free cash flow (TTM)$3.3B
Total cash$8.8B
Total debt$2.7B
Debt / equity8.61
Current ratio3.56
Income Statement
Total revenue (TTM)$14.9B
Revenue per share (TTM)143.56
Gross profit (TTM)$6.5B
EBITDA (TTM)$4.4B
Net income (TTM)$4.4B
EPS diluted (TTM)40.96
Shares outstanding103,021,886
Float shares97,672,523
Profitability
Gross margin43.89%
Operating margin20.66%
EBITDA margin29.38%
Net margin29.65%
Efficiency
Return on assets (TTM)6.13%
Return on equity (TTM)14.55%
Price History
Current price$714.89
52 Week high$821.11
52 Week low$476.49
50 day average$748.84
200 day average$687.56
Average volume (10 day)813,310
1-year beta0.30
1-year price target$875.31
Dividends
Dividend yield0.53%
Dividend rate (annual)$3.76
Payout ratio8.74%
Fundamentals are sourced from yfinance and refreshed daily. Last updated May 10, 2026, 5:41 PM. Empty cells (—) mean yfinance doesn't have that field for this ticker (common for ADRs, recent IPOs, or non-applicable ratios).
Real-time alerts. We'll let you know when a whale you follow files a new 13F, or a stock you follow has insider activity. No weekly digest.
whalstreet
★ WatchlistData from SEC EDGAR · whalstreet.com